We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The updated tool is intended to provide physicians with improved visualization, easier access and tissue apposition, especially in patients with narrow nasal airways. Read More
In two pivotal phase 3 trials, data showed that Glaukos’s combination product iDose TR succeeded in reducing intraocular pressure (IOP) safely. Read More
The FDA has issued a final guidance for laboratories and manufacturers on its policy for reviewing emergency use authorization of tests to diagnose monkeypox, bypassing the draft guidance stage. Read More
Three-year results continue to show that Abbott’s Amplatzer Piccolo Occluder, which was approved by the FDA in 2019, is safe and effective in nonsurgically closing a hole in the heart of premature infants. Read More
AposHealth’s Apos biomechanical knee treatment helped most patients suffering from disabling osteoarthritis (OA) to be able to delay knee replacement surgery for 24 months, according to data from an observational study published in the journal Population Health Management. Read More
A group of researchers representing devicemakers, academic institutions and the FDA has published a list of factors device developers should consider when collecting patient preference information (PPI) to help design trials. Read More